Overview
Deniz specializes on complex legal, commercial and strategic projects in the health and life sciences sector. He advises on transactions and collaborations, disputes in and out of court, market entry and reimbursement pathways, as well as data protection and other compliance challenges of an increasingly digitized industry. His clients involve global pharmaceutical companies and medical device manufacturers, early stage companies with a focus on innovative health products and disruptive business models, as well as investors in German and European health markets.
Deniz has a strong public law background also beyond the health sector. He regularly advises on e-commerce matters and government affairs, including with respect to the COVID-19 pandemic, IT security regulations, foreign trade and foreign investment control.
Deniz has deep economic and market expertise, evidenced by an Executive MBA degree from the University of St. Gallen. He has been recognized as a Rising Star in the German and European health market by The Legal 500, LMG and JUVE. Deniz is the author of numerous articles in the field of health law and regularly speaks at life sciences events.
Results
- Advising a research-based pharmaceutical company in negotiations with the German Federal Ministry of Health concerning the procurement of COVID-19 therapeutics
- Advising a research-based pharmaceutical company in connection with a cooperation agreement regarding the EU-wide distribution of respiratory drugs
- Advised a global internet company on telemedical business models in times of the COVID-19 crisis
- Advising an international technology company on the use of artificial intelligence in the field of X-ray diagnostics
- Advised a medical practice in the context of criminal investigations on suspicion of bribery in the health sector
- Advising a US provider of genetic tests on its market access in Germany
- Advising a machine learning platform on medical device and data protection law issues
Recognitions
- Handelsblatt/Best Lawyers™ 2023 Germany: Leading Lawyer for Pharmaceuticals Law
- LMG 2021: Recognized as European Rising Star in Life Sciences
- The Legal 500 Germany 2021: Recognized as Rising Star in Healthcare and Life Sciences
- JUVE Handbook 2020/2021: Recognized as Rising Star in Healthcare and Life Sciences (under 40)
- Rising Star, Tax – Euromoney Expert Guide 2021
Community
- Federal Association of the Pharmaceutical Industry (BPI)
- Research Group on Pharmaceutical Law at the Philipps University of Marburg, Promotion Circle member
- German-American Lawyers’ Association, member
Credentials
Education
University of St. Gallen, Executive MBA, 2021
King’s College London, LLM, 2013
Higher Regional Court of Wiesbaden, Second State Examination, 2012
Philipps University of Marburg, PhD, 2011
Goethe University of Frankfurt, First State Examination, 2008
Universities of Frankfurt and Lyon, Diploma in French Law, 2007
Admissions
Germany
Languages
English
German
